CD274 and neoplasm: Presence of CMYC+ tumour cells or the high PD-L1+ group, and the combination of these two were significantly poor prognostic factors in patients with TFH+ PTCLs (p = 0.029, p = 0.0004, or p < 0.0001, respectively).